Skip to main content
. 2021 Mar 1;15:633655. doi: 10.3389/fnhum.2021.633655

Table 1.

Subject demographics.

Subject Gender Age (years) Diagnosis (year of first symptom) Disease duration at surgery LEDD (screening/6 months) UPDRS II (screening /6 months) UPDRS III off-med/on-GPi DBS only (screening/6 months) UPDRS III on-med/on-GPi DBS only (screening/ 6 months) UPDRS IV (screening/ 6 months)
1 F 50 2009 (2001) 6 (14) 502.5 577.5 26 22 38 24 23 19 5 7
2 M 52 2008 (2006) 7 (9) 622.5 607.5 23 17 31 37 21 31 5 3
3 M 74 2008 (2005) 7 (10) 275 350 30 40 42 57 34 52 5 6
4 M 60 1995 (1994) 20 (21) 625 625 24 21 49 46 30 41 14 5
5 F 60 2013 (2011) 2 (4) 427.5 405 35 33 40 48 28 42 5 6

UPDRS scores were performed On-GPi DBS only. PPN DBS was not activated during these scales. UPDRS, Unified Parkinson’s Disease Rating Scale; LEDD, levodopa equivalent daily dose; GPi, globus pallidus internus; DBS, deep brain stimulation.